![](/img/cover-not-exists.png)
PCN212 PERSONALIZED DISCRETE EVENT SIMULATION OF PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL FOR FIRST-LINE DOUBLET CHEMOTHERAPY WITH OR WITHOUT BEVACIZUMAB IN METASTATIC COLORECTAL CANCER
Degeling, K., Wong, H.L., Johns, J., Koffijberg, H., Gibbs, P., IJzerman, M.Volume:
22
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.334
Date:
May, 2019
File:
PDF, 381 KB
english, 2019